Panel // Genomics and Advanced Breeding: Boosting Disease Resistance, Productivity & Consumer Trust

09 Apr 2026
Auditorium
Main Stage
  • Gene editing is proving highly effective in tackling livestock diseases, with FDA approval of PRRS-resistant pigs paving the way for wider adoption. What must genetics companies prioritize to achieve scale and acceptance?
  • How can the livestock industry better communicate the welfare, sustainability and disease-resistance benefits of gene editing to address consumer concerns?
  • What new breakthroughs in embryonic stem cell research are transforming breeding strategies and trait selection for commercial herds?
  • How is AI accelerating genetic research, from complex datasets on gene expression and microbiome to using imaging tools for phenotyping and trait analysis?
  • How are genetics companies collaborating with farmers, agtech providers, packers, and retailers to improve value across the supply chain? What characteristics matter most to consumers?
Chairperson
Spencer Swayze
Spencer Swayze, Managing Partner - OSIRIS GROWTH CAPITAL
Speakers
William Herring
William Herring, Vice President of Research and Development - COBB-VANTRESS
Lee Leachman
Lee Leachman, CEO - LEACHMAN CATTLE
Michael Lohuis
Michael Lohuis, VP Research & Innovation - SEMEX
Alison Van Eenennaam
Alison Van Eenennaam, Extension Specialist: Animal Biotechnology and Genomics - UC DAVIS